Medicare Enrolled
Dr. Joseph Hawkins, M.D.
Optician · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hawkins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hawkins?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hawkins
Dr. Joseph Hawkins is an optician specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hawkins performed 88,711 Medicare services across 4,385 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hawkins received a total of $577,572 from 48 pharmaceutical and/or device companies across 1366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hawkins is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$577,572 industry payments
Medicare Practice Summary
Medicare Utilization ↗88,711
Medicare services
Top 1% in CA for optician
4,385
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,436 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 61,950 | $8 | $24 |
| Denosumab injection (Prolia/Xgeva) | 21,360 | $18 | $55 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
915 | $6 | $22 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
901 | $55 | $138 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
899 | $10 | $50 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
885 | $30 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
635 | $81 | $304 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
564 | $126 | $432 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
160 | $44 | $179 |
| New patient office visit, complex (60-74 min) | 60 | $149 | $555 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $50 | $202 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
51 | $24 | $87 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
50 | $5 | $13 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $92 | $428 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $45 | $139 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
29 | $28 | $102 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
23 | $10 | $26 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
20 | $8 | $22 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
17 | $13 | $33 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
17 | $10 | $16 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
13 | $16 | $42 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
12 | $9 | $23 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
11 | $3 | $7 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $48 | $283 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
96.0% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$577,572
Total received (2018-2024)
Avg $82,510/year across 7 years
Top 1% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,366
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$569,419 (98.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,152 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$53,167
2023
$77,942
2022
$46,997
2021
$24,116
2020
$44,251
2019
$170,007
2018
$161,091
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$34,618
Novo Nordisk Inc
$11,380
Amgen Inc.
$6,107
Tandem Diabetes Care, Inc.
$148
Radius Health, Inc.
$142
Dexcom, Inc.
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Antares Pharma, Inc.
$100
ABBVIE INC.
$98
Abbott Laboratories
$94
AstraZeneca Pharmaceuticals LP
$65
Kyowa Kirin, Inc.
$63
Xeris Pharmaceuticals, Inc.
$31
RECORDATI_RARE_DISEASES_INC.
$26
Ultragenyx Pharmaceutical Inc.
$25
Medtronic, Inc.
$22
Top 3 companies account for 98.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$189,288
Novo Nordisk Inc
$159,957
AstraZeneca Pharmaceuticals LP
$95,032
Lilly USA, LLC
$87,851
Radius Health, Inc.
$30,793
AbbVie, Inc.
$7,928
Boehringer Ingelheim Pharmaceuticals, Inc.
$925
Tandem Diabetes Care, Inc.
$765
Abbott Laboratories
$557
Dexcom, Inc.
$505
MannKind Corporation
$476
SANOFI-AVENTIS U.S. LLC
$371
ABBVIE INC.
$313
Mannkind Corporation
$278
Insulet Corporation
$275
Corcept Therapeutics
$179
Bayer HealthCare Pharmaceuticals Inc.
$171
Merck Sharp & Dohme Corporation
$152
Horizon Therapeutics plc
$150
Shire North American Group Inc
$136
Kyowa Kirin, Inc.
$136
UCB, Inc.
$134
Medtronic MiniMed, Inc.
$129
PFIZER INC.
$128
Medtronic, Inc.
$121
Ultragenyx Pharmaceutical Inc.
$104
Xeris Pharmaceuticals, Inc.
$101
Antares Pharma, Inc.
$100
RECORDATI_RARE_DISEASES_INC.
$75
AbbVie Inc.
$47
Supernus Pharmaceuticals, Inc.
$44
Esperion Therapeutics, Inc.
$41
BioMarin Pharmaceutical Inc.
$29
Nevro Corp.
$26
Kowa Pharmaceuticals America, Inc.
$25
Becton, Dickinson and Company
$23
Companion Medical, Inc.
$22
Averitas Pharma Inc.
$22
EUSA Pharma (US) LLC
$21
CeQur Corporation
$20
Roche Diagnostics Corporation
$18
Ferring Pharmaceuticals Inc.
$17
Daiichi Sankyo Inc.
$17
Medtronic USA, Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Amryt Pharma Holdings Ltd
$14
IBSA Pharma Inc.
$13
LifeScan, Inc.
$12
Top 3 companies account for 76.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BYDUREON · CD cobas Analyzer Series · CeQur Simplicity · Creon · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · ISTURISA · InPen · JANUVIA · JARDIANCE · KYPHON Balloon Kyphoplasty · Kerendia · Korlym · LOKELMA · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OT Verio Flex Starter Kit · Omnia · Omnipod · Ozempic · Palynziq · Prolia · QUTENZA · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Strensiq · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in CA.
Geographic Context
Opticians within 10 mi
94
Per 100K population
9.3
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hawkins is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hawkins experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Hawkins performed 61,950 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hawkins receive payments from pharmaceutical companies?
Yes. Dr. Hawkins received a total of $577,572 from 48 companies across 1,366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hawkins's costs compare to other opticians in Fresno?
Dr. Hawkins's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hawkins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Fresno
Browse opticians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology